nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproheptadine—Azatadine—CYP3A4—bone cancer	0.0205	0.332	CrCbGaD
Cyproheptadine—Cyclobenzaprine—CYP3A4—bone cancer	0.0119	0.194	CrCbGaD
Cyproheptadine—Wheezing—Cisplatin—bone cancer	0.0109	0.0249	CcSEcCtD
Cyproheptadine—Haemolytic anaemia—Cisplatin—bone cancer	0.00901	0.0206	CcSEcCtD
Cyproheptadine—Nasal congestion—Cisplatin—bone cancer	0.00893	0.0205	CcSEcCtD
Cyproheptadine—Irritability—Cisplatin—bone cancer	0.00776	0.0178	CcSEcCtD
Cyproheptadine—Neuritis—Epirubicin—bone cancer	0.00771	0.0177	CcSEcCtD
Cyproheptadine—Carbamazepine—CYP3A4—bone cancer	0.00744	0.121	CrCbGaD
Cyproheptadine—Neuritis—Doxorubicin—bone cancer	0.00713	0.0163	CcSEcCtD
Cyproheptadine—Mianserin—CYP3A4—bone cancer	0.00685	0.111	CrCbGaD
Cyproheptadine—Sweating increased—Cisplatin—bone cancer	0.00685	0.0157	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Cisplatin—bone cancer	0.00614	0.0141	CcSEcCtD
Cyproheptadine—Nortriptyline—CYP3A4—bone cancer	0.00613	0.0994	CrCbGaD
Cyproheptadine—Tinnitus—Cisplatin—bone cancer	0.00525	0.012	CcSEcCtD
Cyproheptadine—Photosensitivity—Methotrexate—bone cancer	0.00508	0.0116	CcSEcCtD
Cyproheptadine—Hepatic failure—Methotrexate—bone cancer	0.00497	0.0114	CcSEcCtD
Cyproheptadine—Photosensitivity—Epirubicin—bone cancer	0.00476	0.0109	CcSEcCtD
Cyproheptadine—Hepatic failure—Epirubicin—bone cancer	0.00465	0.0106	CcSEcCtD
Cyproheptadine—Vision blurred—Cisplatin—bone cancer	0.00462	0.0106	CcSEcCtD
Cyproheptadine—Tremor—Cisplatin—bone cancer	0.00459	0.0105	CcSEcCtD
Cyproheptadine—Clozapine—CYP3A4—bone cancer	0.00457	0.0742	CrCbGaD
Cyproheptadine—Increased appetite—Epirubicin—bone cancer	0.00445	0.0102	CcSEcCtD
Cyproheptadine—Photosensitivity—Doxorubicin—bone cancer	0.0044	0.0101	CcSEcCtD
Cyproheptadine—Leukopenia—Cisplatin—bone cancer	0.00438	0.01	CcSEcCtD
Cyproheptadine—Hepatic failure—Doxorubicin—bone cancer	0.0043	0.00985	CcSEcCtD
Cyproheptadine—Irritability—Methotrexate—bone cancer	0.00426	0.00976	CcSEcCtD
Cyproheptadine—Amitriptyline—CYP3A4—bone cancer	0.00425	0.069	CrCbGaD
Cyproheptadine—Convulsion—Cisplatin—bone cancer	0.00424	0.00972	CcSEcCtD
Cyproheptadine—Diplopia—Epirubicin—bone cancer	0.00418	0.00957	CcSEcCtD
Cyproheptadine—Increased appetite—Doxorubicin—bone cancer	0.00411	0.00942	CcSEcCtD
Cyproheptadine—Oedema—Cisplatin—bone cancer	0.004	0.00916	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Cisplatin—bone cancer	0.00391	0.00897	CcSEcCtD
Cyproheptadine—Tachycardia—Cisplatin—bone cancer	0.0039	0.00894	CcSEcCtD
Cyproheptadine—Diplopia—Doxorubicin—bone cancer	0.00386	0.00885	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Cisplatin—bone cancer	0.00386	0.00885	CcSEcCtD
Cyproheptadine—Anorexia—Cisplatin—bone cancer	0.00381	0.00873	CcSEcCtD
Cyproheptadine—Hypotension—Cisplatin—bone cancer	0.00374	0.00856	CcSEcCtD
Cyproheptadine—Paraesthesia—Cisplatin—bone cancer	0.00359	0.00822	CcSEcCtD
Cyproheptadine—Photosensitivity reaction—Methotrexate—bone cancer	0.00352	0.00807	CcSEcCtD
Cyproheptadine—Decreased appetite—Cisplatin—bone cancer	0.00347	0.00796	CcSEcCtD
Cyproheptadine—Drowsiness—Methotrexate—bone cancer	0.00344	0.00788	CcSEcCtD
Cyproheptadine—Pollakiuria—Epirubicin—bone cancer	0.00333	0.00764	CcSEcCtD
Cyproheptadine—Photosensitivity reaction—Epirubicin—bone cancer	0.00329	0.00755	CcSEcCtD
Cyproheptadine—Feeling abnormal—Cisplatin—bone cancer	0.00329	0.00755	CcSEcCtD
Cyproheptadine—Weight increased—Epirubicin—bone cancer	0.00329	0.00753	CcSEcCtD
Cyproheptadine—Drowsiness—Epirubicin—bone cancer	0.00322	0.00737	CcSEcCtD
Cyproheptadine—Agranulocytosis—Methotrexate—bone cancer	0.00321	0.00735	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Epirubicin—bone cancer	0.00316	0.00723	CcSEcCtD
Cyproheptadine—Jaundice—Epirubicin—bone cancer	0.00314	0.00719	CcSEcCtD
Cyproheptadine—Hepatitis—Methotrexate—bone cancer	0.00309	0.00707	CcSEcCtD
Cyproheptadine—Pollakiuria—Doxorubicin—bone cancer	0.00309	0.00707	CcSEcCtD
Cyproheptadine—Photosensitivity reaction—Doxorubicin—bone cancer	0.00305	0.00698	CcSEcCtD
Cyproheptadine—Weight increased—Doxorubicin—bone cancer	0.00304	0.00696	CcSEcCtD
Cyproheptadine—Agranulocytosis—Epirubicin—bone cancer	0.003	0.00688	CcSEcCtD
Cyproheptadine—Drowsiness—Doxorubicin—bone cancer	0.00298	0.00682	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Doxorubicin—bone cancer	0.00292	0.00669	CcSEcCtD
Cyproheptadine—Jaundice—Doxorubicin—bone cancer	0.0029	0.00665	CcSEcCtD
Cyproheptadine—Hepatitis—Epirubicin—bone cancer	0.00289	0.00662	CcSEcCtD
Cyproheptadine—Tinnitus—Methotrexate—bone cancer	0.00288	0.00659	CcSEcCtD
Cyproheptadine—Asthenia—Cisplatin—bone cancer	0.00287	0.00657	CcSEcCtD
Cyproheptadine—Agranulocytosis—Doxorubicin—bone cancer	0.00278	0.00637	CcSEcCtD
Cyproheptadine—Chills—Methotrexate—bone cancer	0.00277	0.00635	CcSEcCtD
Cyproheptadine—Diarrhoea—Cisplatin—bone cancer	0.00274	0.00627	CcSEcCtD
Cyproheptadine—Tinnitus—Epirubicin—bone cancer	0.00269	0.00617	CcSEcCtD
Cyproheptadine—Hepatitis—Doxorubicin—bone cancer	0.00267	0.00612	CcSEcCtD
Cyproheptadine—Chills—Epirubicin—bone cancer	0.00259	0.00594	CcSEcCtD
Cyproheptadine—Vomiting—Cisplatin—bone cancer	0.00254	0.00582	CcSEcCtD
Cyproheptadine—Vision blurred—Methotrexate—bone cancer	0.00253	0.0058	CcSEcCtD
Cyproheptadine—Rash—Cisplatin—bone cancer	0.00252	0.00577	CcSEcCtD
Cyproheptadine—Dermatitis—Cisplatin—bone cancer	0.00252	0.00577	CcSEcCtD
Cyproheptadine—Tinnitus—Doxorubicin—bone cancer	0.00249	0.00571	CcSEcCtD
Cyproheptadine—Tension—Epirubicin—bone cancer	0.00247	0.00565	CcSEcCtD
Cyproheptadine—Nervousness—Epirubicin—bone cancer	0.00244	0.0056	CcSEcCtD
Cyproheptadine—Vertigo—Methotrexate—bone cancer	0.00241	0.00553	CcSEcCtD
Cyproheptadine—Leukopenia—Methotrexate—bone cancer	0.00241	0.00551	CcSEcCtD
Cyproheptadine—Chills—Doxorubicin—bone cancer	0.0024	0.00549	CcSEcCtD
Cyproheptadine—Nausea—Cisplatin—bone cancer	0.00237	0.00544	CcSEcCtD
Cyproheptadine—Vision blurred—Epirubicin—bone cancer	0.00237	0.00543	CcSEcCtD
Cyproheptadine—Convulsion—Methotrexate—bone cancer	0.00233	0.00533	CcSEcCtD
Cyproheptadine—Agitation—Epirubicin—bone cancer	0.00231	0.00529	CcSEcCtD
Cyproheptadine—Tension—Doxorubicin—bone cancer	0.00228	0.00523	CcSEcCtD
Cyproheptadine—Nervousness—Doxorubicin—bone cancer	0.00226	0.00518	CcSEcCtD
Cyproheptadine—Vertigo—Epirubicin—bone cancer	0.00226	0.00518	CcSEcCtD
Cyproheptadine—Syncope—Epirubicin—bone cancer	0.00226	0.00517	CcSEcCtD
Cyproheptadine—Leukopenia—Epirubicin—bone cancer	0.00225	0.00516	CcSEcCtD
Cyproheptadine—Palpitations—Epirubicin—bone cancer	0.00222	0.00509	CcSEcCtD
Cyproheptadine—Confusional state—Methotrexate—bone cancer	0.00221	0.00507	CcSEcCtD
Cyproheptadine—Loss of consciousness—Epirubicin—bone cancer	0.00221	0.00506	CcSEcCtD
Cyproheptadine—Vision blurred—Doxorubicin—bone cancer	0.00219	0.00502	CcSEcCtD
Cyproheptadine—Convulsion—Epirubicin—bone cancer	0.00218	0.00499	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Methotrexate—bone cancer	0.00215	0.00492	CcSEcCtD
Cyproheptadine—Agitation—Doxorubicin—bone cancer	0.00214	0.0049	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Methotrexate—bone cancer	0.00212	0.00486	CcSEcCtD
Cyproheptadine—Vertigo—Doxorubicin—bone cancer	0.00209	0.00479	CcSEcCtD
Cyproheptadine—Anorexia—Methotrexate—bone cancer	0.00209	0.00479	CcSEcCtD
Cyproheptadine—Syncope—Doxorubicin—bone cancer	0.00209	0.00478	CcSEcCtD
Cyproheptadine—Leukopenia—Doxorubicin—bone cancer	0.00208	0.00477	CcSEcCtD
Cyproheptadine—Confusional state—Epirubicin—bone cancer	0.00207	0.00474	CcSEcCtD
Cyproheptadine—Palpitations—Doxorubicin—bone cancer	0.00206	0.00471	CcSEcCtD
Cyproheptadine—Oedema—Epirubicin—bone cancer	0.00205	0.0047	CcSEcCtD
Cyproheptadine—Hypotension—Methotrexate—bone cancer	0.00205	0.0047	CcSEcCtD
Cyproheptadine—Loss of consciousness—Doxorubicin—bone cancer	0.00205	0.00469	CcSEcCtD
Cyproheptadine—Shock—Epirubicin—bone cancer	0.00202	0.00463	CcSEcCtD
Cyproheptadine—Convulsion—Doxorubicin—bone cancer	0.00202	0.00462	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Epirubicin—bone cancer	0.00201	0.0046	CcSEcCtD
Cyproheptadine—Tachycardia—Epirubicin—bone cancer	0.002	0.00459	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Epirubicin—bone cancer	0.00198	0.00455	CcSEcCtD
Cyproheptadine—Insomnia—Methotrexate—bone cancer	0.00198	0.00454	CcSEcCtD
Cyproheptadine—Paraesthesia—Methotrexate—bone cancer	0.00197	0.00451	CcSEcCtD
Cyproheptadine—Anorexia—Epirubicin—bone cancer	0.00196	0.00448	CcSEcCtD
Cyproheptadine—Somnolence—Methotrexate—bone cancer	0.00195	0.00447	CcSEcCtD
Cyproheptadine—Dyspepsia—Methotrexate—bone cancer	0.00193	0.00442	CcSEcCtD
Cyproheptadine—Hypotension—Epirubicin—bone cancer	0.00192	0.00439	CcSEcCtD
Cyproheptadine—Confusional state—Doxorubicin—bone cancer	0.00192	0.00439	CcSEcCtD
Cyproheptadine—Decreased appetite—Methotrexate—bone cancer	0.00191	0.00437	CcSEcCtD
Cyproheptadine—Oedema—Doxorubicin—bone cancer	0.0019	0.00435	CcSEcCtD
Cyproheptadine—Fatigue—Methotrexate—bone cancer	0.00189	0.00433	CcSEcCtD
Cyproheptadine—Shock—Doxorubicin—bone cancer	0.00187	0.00428	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Doxorubicin—bone cancer	0.00186	0.00426	CcSEcCtD
Cyproheptadine—Insomnia—Epirubicin—bone cancer	0.00186	0.00425	CcSEcCtD
Cyproheptadine—Tachycardia—Doxorubicin—bone cancer	0.00185	0.00425	CcSEcCtD
Cyproheptadine—Paraesthesia—Epirubicin—bone cancer	0.00184	0.00422	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Doxorubicin—bone cancer	0.00184	0.00421	CcSEcCtD
Cyproheptadine—Somnolence—Epirubicin—bone cancer	0.00182	0.00418	CcSEcCtD
Cyproheptadine—Anorexia—Doxorubicin—bone cancer	0.00181	0.00415	CcSEcCtD
Cyproheptadine—Feeling abnormal—Methotrexate—bone cancer	0.00181	0.00414	CcSEcCtD
Cyproheptadine—Dyspepsia—Epirubicin—bone cancer	0.00181	0.00414	CcSEcCtD
Cyproheptadine—Decreased appetite—Epirubicin—bone cancer	0.00178	0.00409	CcSEcCtD
Cyproheptadine—Hypotension—Doxorubicin—bone cancer	0.00177	0.00407	CcSEcCtD
Cyproheptadine—Fatigue—Epirubicin—bone cancer	0.00177	0.00405	CcSEcCtD
Cyproheptadine—Constipation—Epirubicin—bone cancer	0.00176	0.00402	CcSEcCtD
Cyproheptadine—Urticaria—Methotrexate—bone cancer	0.00174	0.00399	CcSEcCtD
Cyproheptadine—Insomnia—Doxorubicin—bone cancer	0.00172	0.00394	CcSEcCtD
Cyproheptadine—Paraesthesia—Doxorubicin—bone cancer	0.00171	0.00391	CcSEcCtD
Cyproheptadine—Feeling abnormal—Epirubicin—bone cancer	0.00169	0.00387	CcSEcCtD
Cyproheptadine—Somnolence—Doxorubicin—bone cancer	0.00169	0.00387	CcSEcCtD
Cyproheptadine—Dyspepsia—Doxorubicin—bone cancer	0.00167	0.00383	CcSEcCtD
Cyproheptadine—Decreased appetite—Doxorubicin—bone cancer	0.00165	0.00378	CcSEcCtD
Cyproheptadine—Fatigue—Doxorubicin—bone cancer	0.00164	0.00375	CcSEcCtD
Cyproheptadine—Urticaria—Epirubicin—bone cancer	0.00163	0.00374	CcSEcCtD
Cyproheptadine—Constipation—Doxorubicin—bone cancer	0.00162	0.00372	CcSEcCtD
Cyproheptadine—Asthenia—Methotrexate—bone cancer	0.00157	0.00361	CcSEcCtD
Cyproheptadine—Feeling abnormal—Doxorubicin—bone cancer	0.00157	0.00359	CcSEcCtD
Cyproheptadine—Urticaria—Doxorubicin—bone cancer	0.00151	0.00346	CcSEcCtD
Cyproheptadine—Diarrhoea—Methotrexate—bone cancer	0.0015	0.00344	CcSEcCtD
Cyproheptadine—Asthenia—Epirubicin—bone cancer	0.00147	0.00337	CcSEcCtD
Cyproheptadine—Dizziness—Methotrexate—bone cancer	0.00145	0.00332	CcSEcCtD
Cyproheptadine—Diarrhoea—Epirubicin—bone cancer	0.0014	0.00322	CcSEcCtD
Cyproheptadine—Vomiting—Methotrexate—bone cancer	0.00139	0.00319	CcSEcCtD
Cyproheptadine—Rash—Methotrexate—bone cancer	0.00138	0.00317	CcSEcCtD
Cyproheptadine—Dermatitis—Methotrexate—bone cancer	0.00138	0.00317	CcSEcCtD
Cyproheptadine—Headache—Methotrexate—bone cancer	0.00137	0.00315	CcSEcCtD
Cyproheptadine—Asthenia—Doxorubicin—bone cancer	0.00136	0.00312	CcSEcCtD
Cyproheptadine—Dizziness—Epirubicin—bone cancer	0.00136	0.00311	CcSEcCtD
Cyproheptadine—Vomiting—Epirubicin—bone cancer	0.00131	0.00299	CcSEcCtD
Cyproheptadine—Nausea—Methotrexate—bone cancer	0.0013	0.00298	CcSEcCtD
Cyproheptadine—Diarrhoea—Doxorubicin—bone cancer	0.0013	0.00298	CcSEcCtD
Cyproheptadine—Rash—Epirubicin—bone cancer	0.00129	0.00296	CcSEcCtD
Cyproheptadine—Dermatitis—Epirubicin—bone cancer	0.00129	0.00296	CcSEcCtD
Cyproheptadine—Headache—Epirubicin—bone cancer	0.00129	0.00295	CcSEcCtD
Cyproheptadine—Dizziness—Doxorubicin—bone cancer	0.00126	0.00288	CcSEcCtD
Cyproheptadine—Nausea—Epirubicin—bone cancer	0.00122	0.00279	CcSEcCtD
Cyproheptadine—Vomiting—Doxorubicin—bone cancer	0.00121	0.00277	CcSEcCtD
Cyproheptadine—Rash—Doxorubicin—bone cancer	0.0012	0.00274	CcSEcCtD
Cyproheptadine—Dermatitis—Doxorubicin—bone cancer	0.0012	0.00274	CcSEcCtD
Cyproheptadine—Headache—Doxorubicin—bone cancer	0.00119	0.00273	CcSEcCtD
Cyproheptadine—Nausea—Doxorubicin—bone cancer	0.00113	0.00258	CcSEcCtD
Cyproheptadine—HTR6—Signaling Pathways—GRM4—bone cancer	0.000752	0.0015	CbGpPWpGaD
Cyproheptadine—HTR2A—SIDS Susceptibility Pathways—JUN—bone cancer	0.000735	0.00147	CbGpPWpGaD
Cyproheptadine—UGT1A3—Metabolism—ENO2—bone cancer	0.000735	0.00147	CbGpPWpGaD
Cyproheptadine—CHRM2—SIDS Susceptibility Pathways—JUN—bone cancer	0.000722	0.00144	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—GRM1—bone cancer	0.000717	0.00143	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCR downstream signaling—GNA11—bone cancer	0.000715	0.00142	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—GNA11—bone cancer	0.000711	0.00142	CbGpPWpGaD
Cyproheptadine—HTR6—GPCR downstream signaling—IL3—bone cancer	0.00071	0.00141	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—SMO—bone cancer	0.000709	0.00141	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—GRM1—bone cancer	0.000705	0.00141	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—GRM1—bone cancer	0.000704	0.0014	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—GRM1—bone cancer	0.000702	0.0014	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—GRM1—bone cancer	0.000699	0.00139	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—GRM1—bone cancer	0.000693	0.00138	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—GRM4—bone cancer	0.000686	0.00137	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—RGS1—bone cancer	0.000686	0.00137	CbGpPWpGaD
Cyproheptadine—UGT1A3—Metabolism—DHFR—bone cancer	0.000682	0.00136	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—GRM1—bone cancer	0.000652	0.0013	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—GNA11—bone cancer	0.000649	0.00129	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCR downstream signaling—IL3—bone cancer	0.000648	0.00129	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—IL3—bone cancer	0.000644	0.00128	CbGpPWpGaD
Cyproheptadine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.000638	0.00127	CbGpPWpGaD
Cyproheptadine—UGT1A3—Metabolism—GNA11—bone cancer	0.000637	0.00127	CbGpPWpGaD
Cyproheptadine—DRD2—Circadian rythm related genes—JUN—bone cancer	0.00061	0.00122	CbGpPWpGaD
Cyproheptadine—CHRM1—Circadian rythm related genes—JUN—bone cancer	0.000597	0.00119	CbGpPWpGaD
Cyproheptadine—CHRM1—Regulation of Actin Cytoskeleton—EGFR—bone cancer	0.000597	0.00119	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—GRM1—bone cancer	0.000595	0.00119	CbGpPWpGaD
Cyproheptadine—CHRM3—Regulation of Actin Cytoskeleton—EGFR—bone cancer	0.000595	0.00119	CbGpPWpGaD
Cyproheptadine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—bone cancer	0.000589	0.00117	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—IL3—bone cancer	0.000588	0.00117	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—GNA11—bone cancer	0.000579	0.00115	CbGpPWpGaD
Cyproheptadine—UGT1A3—Metabolism—CYP3A4—bone cancer	0.000578	0.00115	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—GNA11—bone cancer	0.000576	0.00115	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—SMO—bone cancer	0.000575	0.00115	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—SMO—bone cancer	0.000572	0.00114	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—GRM4—bone cancer	0.000556	0.00111	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—RGS1—bone cancer	0.000556	0.00111	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—GRM4—bone cancer	0.000553	0.0011	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—RGS1—bone cancer	0.000553	0.0011	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—GNA11—bone cancer	0.000526	0.00105	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—IL3—bone cancer	0.000525	0.00105	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—GNA11—bone cancer	0.000523	0.00104	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—IL3—bone cancer	0.000523	0.00104	CbGpPWpGaD
Cyproheptadine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.000515	0.00103	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—GNA11—bone cancer	0.000509	0.00101	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—SMO—bone cancer	0.000505	0.00101	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—GNA11—bone cancer	0.000501	0.000998	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—GNA11—bone cancer	0.000499	0.000995	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—GNA11—bone cancer	0.000498	0.000992	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—SMO—bone cancer	0.000497	0.00099	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—GNA11—bone cancer	0.000496	0.000989	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—SMO—bone cancer	0.000496	0.000988	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—SMO—bone cancer	0.000494	0.000985	CbGpPWpGaD
Cyproheptadine—UGT1A3—Metabolism—GSTP1—bone cancer	0.000494	0.000985	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—SMO—bone cancer	0.000493	0.000982	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—GNA11—bone cancer	0.000491	0.000979	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—GRM4—bone cancer	0.000488	0.000973	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—RGS1—bone cancer	0.000488	0.000973	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—SMO—bone cancer	0.000488	0.000973	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—GRM1—bone cancer	0.000482	0.000961	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—RGS1—bone cancer	0.000481	0.000958	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—GRM4—bone cancer	0.000481	0.000958	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—GRM1—bone cancer	0.00048	0.000956	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—GRM4—bone cancer	0.00048	0.000956	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—RGS1—bone cancer	0.00048	0.000956	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—GRM4—bone cancer	0.000478	0.000953	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—RGS1—bone cancer	0.000478	0.000953	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—IL3—bone cancer	0.000477	0.000951	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—RGS1—bone cancer	0.000477	0.00095	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—GRM4—bone cancer	0.000477	0.00095	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—IL3—bone cancer	0.000475	0.000946	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—RGS1—bone cancer	0.000472	0.00094	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—GRM4—bone cancer	0.000472	0.00094	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—GNA11—bone cancer	0.000462	0.000921	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—IL3—bone cancer	0.000461	0.000919	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—SMO—bone cancer	0.000459	0.000915	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—GNA11—bone cancer	0.000455	0.000906	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—IL3—bone cancer	0.000454	0.000904	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—GNA11—bone cancer	0.000454	0.000904	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—IL3—bone cancer	0.000453	0.000902	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—GNA11—bone cancer	0.000452	0.000901	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—IL3—bone cancer	0.000451	0.0009	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—GNA11—bone cancer	0.000451	0.000898	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—IL3—bone cancer	0.00045	0.000897	CbGpPWpGaD
Cyproheptadine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.000447	0.000891	CbGpPWpGaD
Cyproheptadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.000446	0.00089	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—GNA11—bone cancer	0.000446	0.000889	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—IL3—bone cancer	0.000446	0.000888	CbGpPWpGaD
Cyproheptadine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.000445	0.000887	CbGpPWpGaD
Cyproheptadine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.000444	0.000884	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—GRM1—bone cancer	0.000424	0.000844	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—GNA11—bone cancer	0.00042	0.000837	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—SMO—bone cancer	0.000419	0.000835	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—IL3—bone cancer	0.000419	0.000835	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—GRM1—bone cancer	0.000417	0.00083	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—GRM1—bone cancer	0.000416	0.000829	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—GRM1—bone cancer	0.000414	0.000826	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—GRM1—bone cancer	0.000413	0.000823	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—IL3—bone cancer	0.000412	0.000821	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—IL3—bone cancer	0.000411	0.00082	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—IL3—bone cancer	0.00041	0.000817	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—GRM1—bone cancer	0.000409	0.000815	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—IL3—bone cancer	0.000409	0.000814	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—IL3—bone cancer	0.000405	0.000806	CbGpPWpGaD
Cyproheptadine—DRD2—Circadian rythm related genes—TP53—bone cancer	0.000403	0.000803	CbGpPWpGaD
Cyproheptadine—CHRM1—Circadian rythm related genes—TP53—bone cancer	0.000394	0.000786	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—ATF1—bone cancer	0.00039	0.000778	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—GNA11—bone cancer	0.000383	0.000764	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—IL3—bone cancer	0.000381	0.000759	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—ENO2—bone cancer	0.000367	0.000732	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—ATF1—bone cancer	0.000356	0.00071	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—IL3—bone cancer	0.000348	0.000693	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—DHFR—bone cancer	0.000341	0.000679	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—SMO—bone cancer	0.00034	0.000677	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—SMO—bone cancer	0.000338	0.000674	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—TGFBR2—bone cancer	0.000326	0.000649	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—GNA11—bone cancer	0.000318	0.000635	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—GNA11—bone cancer	0.000311	0.000619	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—GNA11—bone cancer	0.000309	0.000616	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—IGF1R—bone cancer	0.000306	0.00061	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—SMO—bone cancer	0.000298	0.000595	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—TGFBR2—bone cancer	0.000297	0.000592	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—SMO—bone cancer	0.000294	0.000585	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—SMO—bone cancer	0.000293	0.000584	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—SMO—bone cancer	0.000292	0.000582	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—SMO—bone cancer	0.000291	0.00058	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—ATF1—bone cancer	0.000289	0.000576	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—CYP3A4—bone cancer	0.000289	0.000575	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—SMO—bone cancer	0.000288	0.000574	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—ATF1—bone cancer	0.000287	0.000573	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—IL3—bone cancer	0.000282	0.000562	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—IL3—bone cancer	0.00028	0.000559	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—IGF1R—bone cancer	0.00028	0.000557	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—GNA11—bone cancer	0.000273	0.000544	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—GNA11—bone cancer	0.000269	0.000535	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—GNA11—bone cancer	0.000268	0.000534	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—GNA11—bone cancer	0.000267	0.000532	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—GNA11—bone cancer	0.000266	0.000531	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—GNA11—bone cancer	0.000264	0.000525	CbGpPWpGaD
Cyproheptadine—UGT1A3—Metabolism—PTGS2—bone cancer	0.000256	0.00051	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—ATF1—bone cancer	0.000254	0.000506	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—ATF1—bone cancer	0.00025	0.000498	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—ATF1—bone cancer	0.000249	0.000496	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—ATF1—bone cancer	0.000248	0.000495	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—ATF1—bone cancer	0.000248	0.000493	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IL3—bone cancer	0.000247	0.000493	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—GSTP1—bone cancer	0.000247	0.000492	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—ATF1—bone cancer	0.000245	0.000488	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IL3—bone cancer	0.000243	0.000485	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IL3—bone cancer	0.000243	0.000484	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IL3—bone cancer	0.000242	0.000483	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IL3—bone cancer	0.000241	0.000481	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—TGFBR2—bone cancer	0.000241	0.00048	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—TGFBR2—bone cancer	0.00024	0.000478	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IL3—bone cancer	0.000239	0.000476	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—IGF1R—bone cancer	0.000227	0.000452	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—IGF1R—bone cancer	0.000226	0.00045	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—KIT—bone cancer	0.000222	0.000443	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—TGFBR2—bone cancer	0.000212	0.000422	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—BRAF—bone cancer	0.000209	0.000416	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—TGFBR2—bone cancer	0.000208	0.000415	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—TGFBR2—bone cancer	0.000208	0.000414	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—TGFBR2—bone cancer	0.000207	0.000413	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—TGFBR2—bone cancer	0.000206	0.000411	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—TGFBR2—bone cancer	0.000204	0.000407	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—KIT—bone cancer	0.000203	0.000404	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—EGFR—bone cancer	0.000202	0.000403	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IGF1R—bone cancer	0.000199	0.000397	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IGF1R—bone cancer	0.000196	0.00039	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IGF1R—bone cancer	0.000195	0.00039	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IGF1R—bone cancer	0.000195	0.000388	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IGF1R—bone cancer	0.000194	0.000387	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IGF1R—bone cancer	0.000192	0.000383	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—BRAF—bone cancer	0.000191	0.00038	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—EGFR—bone cancer	0.000185	0.000368	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—MDM2—bone cancer	0.000175	0.000349	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—KIT—bone cancer	0.000164	0.000328	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—KIT—bone cancer	0.000164	0.000326	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—MDM2—bone cancer	0.00016	0.000318	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—BRAF—bone cancer	0.000155	0.000308	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—BRAF—bone cancer	0.000154	0.000306	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—JUN—bone cancer	0.000152	0.000303	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—EGFR—bone cancer	0.00015	0.000299	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—EGFR—bone cancer	0.000149	0.000297	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—MMP9—bone cancer	0.000148	0.000295	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—KIT—bone cancer	0.000144	0.000288	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—KIT—bone cancer	0.000142	0.000283	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—KIT—bone cancer	0.000142	0.000283	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—KIT—bone cancer	0.000141	0.000282	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—KIT—bone cancer	0.000141	0.000281	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—KIT—bone cancer	0.000139	0.000278	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—JUN—bone cancer	0.000139	0.000277	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—BRAF—bone cancer	0.000136	0.00027	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—MMP9—bone cancer	0.000135	0.000269	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—BRAF—bone cancer	0.000134	0.000266	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—BRAF—bone cancer	0.000133	0.000266	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—BRAF—bone cancer	0.000133	0.000265	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—BRAF—bone cancer	0.000132	0.000264	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—EGFR—bone cancer	0.000132	0.000262	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—BRAF—bone cancer	0.000131	0.000261	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MDM2—bone cancer	0.00013	0.000258	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—EGFR—bone cancer	0.000129	0.000258	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—EGFR—bone cancer	0.000129	0.000257	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MDM2—bone cancer	0.000129	0.000257	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—EGFR—bone cancer	0.000129	0.000257	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—EGFR—bone cancer	0.000128	0.000256	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PTGS2—bone cancer	0.000128	0.000255	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—EGFR—bone cancer	0.000127	0.000253	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—EGFR—bone cancer	0.00012	0.000238	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MDM2—bone cancer	0.000114	0.000227	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—JUN—bone cancer	0.000113	0.000224	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—JUN—bone cancer	0.000112	0.000223	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MDM2—bone cancer	0.000112	0.000223	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MDM2—bone cancer	0.000112	0.000223	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MDM2—bone cancer	0.000111	0.000222	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MDM2—bone cancer	0.000111	0.000221	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MDM2—bone cancer	0.00011	0.000219	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MMP9—bone cancer	0.00011	0.000218	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—EGFR—bone cancer	0.000109	0.000218	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MMP9—bone cancer	0.000109	0.000217	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—TP53—bone cancer	0.0001	0.0002	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—JUN—bone cancer	9.88e-05	0.000197	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—JUN—bone cancer	9.73e-05	0.000194	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—JUN—bone cancer	9.7e-05	0.000193	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—JUN—bone cancer	9.67e-05	0.000193	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—JUN—bone cancer	9.64e-05	0.000192	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MMP9—bone cancer	9.62e-05	0.000192	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—JUN—bone cancer	9.55e-05	0.00019	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MMP9—bone cancer	9.46e-05	0.000189	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MMP9—bone cancer	9.44e-05	0.000188	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MMP9—bone cancer	9.41e-05	0.000188	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MMP9—bone cancer	9.38e-05	0.000187	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MMP9—bone cancer	9.29e-05	0.000185	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—TP53—bone cancer	9.16e-05	0.000183	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—EGFR—bone cancer	8.85e-05	0.000176	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—EGFR—bone cancer	8.81e-05	0.000175	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—EGFR—bone cancer	7.77e-05	0.000155	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—EGFR—bone cancer	7.65e-05	0.000152	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—EGFR—bone cancer	7.63e-05	0.000152	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—EGFR—bone cancer	7.61e-05	0.000152	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—EGFR—bone cancer	7.58e-05	0.000151	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—EGFR—bone cancer	7.51e-05	0.00015	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—TP53—bone cancer	7.43e-05	0.000148	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—TP53—bone cancer	7.39e-05	0.000147	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—TP53—bone cancer	6.52e-05	0.00013	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—TP53—bone cancer	6.42e-05	0.000128	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—TP53—bone cancer	6.41e-05	0.000128	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—TP53—bone cancer	6.39e-05	0.000127	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—TP53—bone cancer	6.37e-05	0.000127	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—TP53—bone cancer	6.3e-05	0.000126	CbGpPWpGaD
